A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/202
A61K 31/70 (2006.01)
Patent
CA 1302265
ABSTRACT A composition for site-specific delivery of an opioid antagonist to the intestine of a subject without substantial systemic effects, comprising nalmefene-3.beta.-D-glucuronide or naltrexone-3.beta.-D-glucuronide in an amount sufficient to provide opioid antagonism to the intestine of the subject and a pharmaceutically acceptable carrier for oral admin- istration, preferably in the form of capsules or tablets.
556617
Dixon Ross
Smulkowski Maciej M.
Tuttle Ronald R.
Baker Norton Pharmaceuticals Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Glucuronic acid derivatives of opioid antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucuronic acid derivatives of opioid antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucuronic acid derivatives of opioid antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1176741